References

1. Vanderver A, Prust M, Tonduti D, et al. Case definition and classification of leukodystrophies and leukoencephalopathies. Mol Genet Metab. 2015;114(4):494-500.
2. Caplan LR. Binswanger’s disease–revisited. Neurology. 1995;45(4):626-33.
3. Loeb, C. Binswanger’s disease is not a single entity. Neurol Sci. 2000;21:343–348.
https://doi.org/10.1007/s1007200700484. Ropper AH, Adams RD, Victor M, Brown RH, Victor M. Adams and Victor’s Principles of Neurology 8th edition. New York: McGraw-Hill Medical Pub. Division, 2005:831-832.
5. Huisa BN, Rosenberg GA. Binswanger’s disease: toward a diagnosis agreement and therapeutic approach. Expert Rev Neurother. 2014;14(10):1203-13.
6. Barry Erhardt E, Pesko JC, Prestopnik J, Thompson J, Caprihan A, Rosenberg GA. Biomarkers identify the Binswanger type of vascular cognitive impairment. J Cereb Blood Flow Metab. 2019;39(8):1602-1612.
7. Miller Fisher, C. Binswanger’s encephalopathy: a review. J Neurol. 1989;236 :65–79. https://doi.org/10.1007/BF00314400
8. Opriș L. Imagistica cerebrală prin Rezonanță Magnetică [Brain MRI imaging]. Timișoara: Solness, 2004:253-257.
9. Salomon A, Yeates AE, Burger PC, Heinz ER. Subcortical arteriosclerotic encephalopathy: brain stem findings with MR imaging. Radiology. 1987;165(3):625-
10. Schiffmann R, Van der Knaap MS. Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology. 2009;72(8):750-9.
11. Berger JR, Aksamit AJ, Clifford DB, et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology.
2013;80(15):1430-31.
12. Misbah SA. Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency. Clin Exp Immunol. 2017 Jun.; 188(3):342-352.
13. Berlit P, Kraemer M. Cerebral vasculitis in adults: what are the steps in order to establish the diagnosis? Red flags and pitfalls. Clin Exp Immunol. 2014;175(3):419-424
14. Beuker C, Schmidt A, Strunk D, et al. Primary angiitis of the central nervous system: diagnosis and treatment. Ther Adv Neurol Disord. 2018;11:1756286418785071.
15. Keogh CF, Andrews GT, Spacey SD et-al. Neuroimaging features of heroin inhalation toxicity: ”chasing the dragon”. AJR Am J Roentgenol. 2003;180 (3): 847-850.
16. Kaufman MJ. Brain imaging in substance abuse : Research, Clinical, and Forensic Applications (Forensic Science and Medicine). 2001, Humana Press.
17. Filley CM, Halliday W, Kleinschmidt-Demasters BK. The Effects of Toluene on the Central Nervous System, Journal of Neuropathology & Experimental Neurology. 2004;63(1):1–12.
18. Haziot MEJ, Barbosa SP jr, Vidal JE, De Oliveira FTM, De Oliveira ACP.
Neuroimaging of HIV-associated neurocognitive disorders. Dement Neuropsychol. 2015;9(4):380-384.
19. Cocozza S, Russo C, Pontillo G, Pisani A, Brunetti A. Neuroimaging in Fabry disease: current knowledge and future directions. Insights Imaging. 2018;9(6):10771088.
20. Mehta A, Widmer U. Natural history of Fabry disease. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS.
Oxford: Oxford PharmaGenesis; 2006. Chapter 19. Available from: https://www.ncbi.nlm.nih.gov/books/NBK11572/
21. Iadecola C. The pathobiology of vascular dementia. Neuron 2013;80(4):844-66
22. Rosenberg GA. Matrix Metalloproteinase-Mediated Neuroinflammation in Vascular Cognitive Impairment of the Binswanger Type. Cell Mol Neurobiol. 2016;36(2):195-202.
23. Huisa BN, Caprihan A, Thompson J, Prestopnik J, Qualls CR, Rosenberg GA. Long-Term Blood-Brain Barrier Permeability Changes in Binswanger Disease. Stroke. 2015;46(9):2413-8.
24. Llorens, F, Hermann P, Villar-Piqué A, et al. Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia. Nat Commun 11, 619 (2020). https://doi.org/10.1038/s41467-020-14373-2
Figure 1. A) Axial cross-section at the level of the body of lateral ventricles. B) Axial cross-section of the basal ganglia. C) Axial cross-section of the midbrain. D) Axial cross-section of the pons E) Axial cross section of the cerebellum and the medulla oblongata